SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines von Shen, Xiaoying, Tang, Haili, McDanal, Charlene, Wagh, Kshitij, Fischer, William, Theiler, James, Yoon, Hyejin, Li, Dapeng, Haynes, Barton F., Sanders, Kevin O., Gnanakaran, Sandrasegaram, Hengartner, Nick, Pajon, Rolando, Smith, Gale, Glenn, Gregory M., Korber, Bette, Montefiori, David C.

Volltext

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351 von Shen, Xiaoying, Tang, Haili, Pajon, Rolando, Smith, Gale, Glenn, Gregory M, Shi, Wei, Korber, Bette, Montefiori, David C

Volltext

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine von Keech, Cheryl, Albert, Gary, Cho, Iksung, Robertson, Andreana, Reed, Patricia, Neal, Susan, Plested, Joyce S, Zhu, Mingzhu, Cloney-Clark, Shane, Zhou, Haixia, Smith, Gale, Patel, Nita, Frieman, Matthew B, Haupt, Robert E, Logue, James, McGrath, Marisa, Weston, Stuart, Piedra, Pedro A, Desai, Chinar, Callahan, Kathleen, Lewis, Maggie, Price-Abbott, Patricia, Formica, Neil, Shinde, Vivek, Fries, Louis, Lickliter, Jason D, Griffin, Paul, Wilkinson, Bethanie, Glenn, Gregory M

Volltext

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial von Formica, Neil, Mallory, Raburn, Albert, Gary, Robinson, Michelle, Plested, Joyce S., Cho, Iksung, Robertson, Andreana, Dubovsky, Filip, Glenn, Gregory M.

Volltext

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge von Guebre-Xabier, Mimi, Patel, Nita, Tian, Jing-Hui, Zhou, Bin, Maciejewski, Sonia, Lam, Kristal, Portnoff, Alyse D., Massare, Michael J., Frieman, Matthew B., Piedra, Pedro A., Ellingsworth, Larry, Glenn, Gregory, Smith, Gale

Volltext

A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine von Fries, Louis F, Smith, Gale E, Glenn, Gregory M

Volltext

Per‐ and polyfluoroalkyl substances and their alternatives in paper food packaging von Glenn, Gregory, Shogren, Randal, Jin, Xing, Orts, William, Hart‐Cooper, William, Olson, Lauren

Volltext

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial von Datoo, Mehreen S, Natama, Magloire H, Somé, Athanase, Traoré, Ousmane, Rouamba, Toussaint, Bellamy, Duncan, Yameogo, Prisca, Valia, Daniel, Tegneri, Moubarak, Ouedraogo, Florence, Soma, Rachidatou, Sawadogo, Seydou, Sorgho, Faizatou, Derra, Karim, Rouamba, Eli, Orindi, Benedict, Ramos Lopez, Fernando, Flaxman, Amy, Cappuccini, Federica, Kailath, Reshma, Elias, Sean, Mukhopadhyay, Ekta, Noe, Andres, Cairns, Matthew, Lawrie, Alison, Roberts, Rachel, Valéa, Innocent, Sorgho, Hermann, Williams, Nicola, Glenn, Gregory, Fries, Louis, Reimer, Jenny, Ewer, Katie J, Shaligram, Umesh, Hill, Adrian V S, Tinto, Halidou

Volltext

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages von Bhiman, Jinal N., Richardson, Simone I., Lambson, Bronwen E., Kgagudi, Prudence, Mzindle, Nonkululeko, Kaldine, Haajira, Crowther, Carol, Gray, Glenda, Bekker, Linda-Gail, Shinde, Vivek, Bennett, Chijioke, Glenn, Gregory M., Madhi, Shabir A., Moore, Penny L.

Volltext

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico von Dunkle, Lisa M, Kotloff, Karen L, Gay, Cynthia L, Áñez, Germán, Adelglass, Jeffrey M, Barrat Hernández, Alejandro Q, Harper, Wayne L, Duncanson, Daniel M, McArthur, Monica A, Florescu, Diana F, McClelland, R. Scott, Garcia-Fragoso, Veronica, Riesenberg, Robert A, Musante, David B, Fried, David L, Safirstein, Beth E, McKenzie, Mark, Jeanfreau, Robert J, Kingsley, Jeffrey K, Henderson, Jeffrey A, Lane, Dakotah C, Ruíz-Palacios, Guillermo M, Corey, Lawrence, Neuzil, Kathleen M, Coombs, Robert W, Greninger, Alex L, Hutter, Julia, Ake, Julie A, Smith, Katherine, Woo, Wayne, Cho, Iksung, Glenn, Gregory M, Dubovsky, Filip

Volltext

Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial von Datoo, Mehreen S, Natama, Hamtandi Magloire, Somé, Athanase, Bellamy, Duncan, Traoré, Ousmane, Rouamba, Toussaint, Tahita, Marc Christian, Ido, N Félix André, Yameogo, Prisca, Valia, Daniel, Millogo, Aida, Ouedraogo, Florence, Soma, Rachidatou, Sawadogo, Seydou, Sorgho, Faizatou, Derra, Karim, Rouamba, Eli, Ramos-Lopez, Fernando, Cairns, Matthew, Provstgaard-Morys, Samuel, Aboagye, Jeremy, Lawrie, Alison, Roberts, Rachel, Valéa, Innocent, Sorgho, Hermann, Williams, Nicola, Glenn, Gregory, Fries, Louis, Reimer, Jenny, Ewer, Katie J, Shaligram, Umesh, Hill, Adrian V S, Tinto, Halidou

Volltext

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age von Glenn, Gregory M., Fries, Louis F., Thomas, D. Nigel, Smith, Gale, Kpamegan, Eloi, Lu, Hanxin, Flyer, David, Jani, Dewal, Hickman, Somia P., Piedra, Pedro A.

Volltext

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice von Tian, Jing-Hui, Patel, Nita, Haupt, Robert, Zhou, Haixia, Weston, Stuart, Hammond, Holly, Logue, James, Portnoff, Alyse D., Norton, James, Guebre-Xabier, Mimi, Zhou, Bin, Jacobson, Kelsey, Maciejewski, Sonia, Khatoon, Rafia, Wisniewska, Malgorzata, Moffitt, Will, Kluepfel-Stahl, Stefanie, Ekechukwu, Betty, Papin, James, Boddapati, Sarathi, Jason Wong, C., Piedra, Pedro A., Frieman, Matthew B., Massare, Michael J., Fries, Louis, Bengtsson, Karin Lövgren, Stertman, Linda, Ellingsworth, Larry, Glenn, Gregory, Smith, Gale

Volltext

Solution blow spinning: A new method to produce micro- and nanofibers from polymer solutions von Medeiros, Eliton S, Glenn, Gregory M, Klamczynski, Artur P, Orts, William J, Mattoso, Luiz H.C

Volltext

Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats von Smith, Gale, Raghunandan, Rama, Wu, Yingyun, Liu, Ye, Massare, Michael, Nathan, Margret, Zhou, Bin, Lu, Hanxin, Boddapati, Sarathi, Li, Jingning, Flyer, David, Glenn, Gregory

Volltext

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice von Coleman, Christopher M, Liu, Ye V, Mu, Haiyan, Taylor, Justin K, Massare, Michael, Flyer, David C, Glenn, Gregory M, Smith, Gale E, Frieman, Matthew B

Volltext

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection von Coleman, Christopher M, Venkataraman, Thiagarajan, Liu, Ye V, Glenn, Gregory M, Smith, Gale E, Flyer, David C, Frieman, Matthew B

Volltext

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of... von August, Allison, Glenn, Gregory M, Kpamegan, Eloi, Hickman, Somia P, Jani, Dewal, Lu, Hanxin, Thomas, D. Nigel, Wen, Judy, Piedra, Pedro A, Fries, Louis F

Volltext

NVX-CoV2373 vaccination induces functional SARS-CoV-2–specific CD4+ and CD8+ T cell responses von Rydyznski Moderbacher, Carolyn, Kim, Christina, Mateus, Jose, Plested, Joyce, Zhu, Mingzhu, Cloney-Clark, Shane, Weiskopf, Daniela, Sette, Alessandro, Fries, Louis, Glenn, Gregory, Crotty, Shane

Volltext

Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants von Muňoz, Flor M, Swamy, Geeta K, Hickman, Somia P, Agrawal, Sapeckshita, Piedra, Pedro A, Glenn, Gregory M, Patel, Nita, August, Allison M, Cho, Iksung, Fries, Louis

Volltext